Literature DB >> 9437565

Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods.

M S Nobler1, H A Sackeim, J R Moeller, J Prudic, E Petkova, C Waternaux.   

Abstract

Although electroconvulsive therapy (ECT) is believed to have a rapid onset of antidepressant activity, there has been limited investigation in this area. This study contrasted alternative statistical methods for testing treatment group differences in the rapidity of clinical response to ECT. Patients with major depression were randomly assigned to receive right unilateral or bilateral ECT and low or high electrical dosage relative to seizure threshold. The 24-item Hamilton Rating Scale for Depression (HRSD) was administered by blinded clinical raters twice weekly (non-treatment days). We evaluated four alternative statistical strategies. Two methods considered time to improvement as a dependent variable: (a) time (treatment number) to reach various cutoffs for percentage decrease in HRSD from baseline; and (b) survival analysis using the same cutoffs for percentage decreases as endpoints. Two methods considered time to improvement as an independent variable: (c) the slope of linear regression of HRSD scores against treatment number; and (d) a random regression model using the HRSD scores as repeated measures. The statistical methods differed in whether or not omnibus group differences were observed, the criterion level of improvement associated with group differences, and the results of pairwise comparisons establishing specific therapeutic advantages. Survival analysis generally displayed the greatest sensitivity in detecting treatment group differences.

Entities:  

Mesh:

Year:  1997        PMID: 9437565

Source DB:  PubMed          Journal:  Convuls Ther        ISSN: 0749-8055


  11 in total

Review 1.  Improvement of depression following transcranial magnetic stimulation.

Authors:  M S George; Z Nahas; F A Kozel; J Goldman; M Molloy; N Oliver
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

Review 2.  Convergent Mechanisms Underlying Rapid Antidepressant Action.

Authors:  Panos Zanos; Scott M Thompson; Ronald S Duman; Carlos A Zarate; Todd D Gould
Journal:  CNS Drugs       Date:  2018-03       Impact factor: 5.749

3.  [Vagus nerve stimulation, repetitive transcranial magnetic stimulation, and electroconvulsive therapy in the treatment of depressive disorders].

Authors:  M Bajbouj; I Heuser
Journal:  Nervenarzt       Date:  2005-01       Impact factor: 1.214

Review 4.  Speed of antidepressant response to electroconvulsive therapy in bipolar disorder vs. major depressive disorder.

Authors:  Smita Agarkar; Stephen W Hurt; Robert C Young
Journal:  Psychiatry Res       Date:  2018-03-01       Impact factor: 3.222

5.  Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.

Authors:  Chadi G Abdallah; Madonna Fasula; Ben Kelmendi; Gerard Sanacora; Robert Ostroff
Journal:  J ECT       Date:  2012-09       Impact factor: 3.635

6.  Comparison of therapeutic efficacy of ect and imipramine : a randomized controlled trial.

Authors:  C P Selvan; P M Mayur; B N Gangadhar; N Janakiramaiah; D K Subbakrishna; N Murali
Journal:  Indian J Psychiatry       Date:  1999-07       Impact factor: 1.759

7.  Robust and sustained effect of ketamine infusions coadministered with conventional antidepressants in a patient with refractory major depression.

Authors:  José Manuel Montes; Elena Luján; Fernado Pascual; Jose María Beleña; Jose Luis Perez-Santar; Luis Javier Irastorza; Jerónimo Saiz-Ruiz
Journal:  Case Rep Psychiatry       Date:  2015-03-04

8.  ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis.

Authors:  Ching-Hua Lin; Chun-Jen Huang; Cheng-Chung Chen
Journal:  Int J Neuropsychopharmacol       Date:  2018-01-01       Impact factor: 5.176

9.  Testing a variable-length Cognitive Processing Therapy intervention for posttraumatic stress disorder in active duty military: Design and methodology of a clinical trial.

Authors:  Jennifer Schuster Wachen; Katherine A Dondanville; Stacey Young-McCaughan; Jim Mintz; M Danet Lapiz-Bluhm; Kristi E Pruiksma; Col Jeffrey S Yarvis; Alan L Peterson; Patricia A Resick
Journal:  Contemp Clin Trials Commun       Date:  2019-05-23

10.  Study design comparing written exposure therapy to cognitive processing therapy for PTSD among military service members: A noninferiority trial.

Authors:  Denise M Sloan; Brian P Marx; Patricia A Resick; Stacey Young-McCaughan; Katherine A Dondanville; Jim Mintz; Brett T Litz; Alan L Peterson
Journal:  Contemp Clin Trials Commun       Date:  2019-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.